US Pharma MarketingThe post Leo Cancer Care raises $65m for upright radiotherapy platform appeared first on Medical Device Network.
Leo Cancer Care raises $65m for upright radiotherapy platform
An upright positioning system and CT scanner for proton therapy, Leo’s Marie radiotherapy platform gained FDA clearance in July 2025. An upright positioning system and CT scanner for proton therapy, Leo’s Marie radiotherapy platform gained FDA clearance in July 2025. Leo’s radiotherapy system removes the need for a gantry, instead rotating the patient under the system’s laser beam. Credit: PR Newswire / Leo Cancer Care. Leo Cancer Care has raised $65m to advance manufacturing and commercial deployment activities surrounding its upright radiotherapy platform. The company’s oversubscribed Series D financing round was led by Yu Galaxy and featured participation from new…
An upright positioning system and CT scanner for proton therapy, Leo’s Marie radiotherapy platform gained FDA clearance in July 2025.
Source: Medical Device Network